111, Inc. Stock News

SHANGHAI , April 30, 2024 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine a

111, Inc. (YI) Q4 2023 Earnings Call Transcript

SHANGHAI , March 1, 2024 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine an

In the US business landscape, strategic mergers and acquisitions often set the stage for remarkable returns for shareholders. In the wake of economic shifts, three key M&A plays emerge as focal points

SHANGHAI , Nov. 13, 2023 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine an

SHANGHAI , May 25, 2023 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and

111, Inc. (NASDAQ:YI ) Q4 2022 Earnings Conference Call March 23, 2023 7:30 AM ET Company Participants Gang Yu - Co-Founder and Executive Chairman Junling Liu - Co-Founder, Chairman and Chief Executiv

SHANGHAI , March 2, 2023 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine a

111, Inc. has received a non-binding proposal to be acquired by a consortium led by the company's founders at $3.66/ADS. YI share price has recently soared, jumping to as much as 9% above the offer an

111, Inc. (NASDAQ:YI ) Q3 2022 Earnings Conference Call December 1, 2022 7:30 AM ET Company Participants Gang Yu - Co-Founder and Executive Chairman Junling Liu - Co-Founder, Chairman and Chief Execut

SHANGHAI , Nov. 8, 2022 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and

111, Inc. (NASDAQ:YI ) Q2 2022 Earnings Conference Call August 25, 2022 7:30 AM ET Company Participants Monica Mu - Investor Relations Director Gang Yu - Co-Founder and Executive Chairman Junling Liu

SHANGHAI , Aug. 5, 2022 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and

111, Inc. kept growing despite strong headwinds from pandemic lockdowns, which will continue to plague Q2 but not enough to lower FY22 outlook. 111, Inc. has plenty of growth avenues, particularly in

SHANGHAI, May 26, 2022 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and